Shandong Boan Biotechnology Co., Ltd. (HKG:6955)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
17.60
+0.50 (2.92%)
Last updated: Jul 17, 2025
Market Cap9.87B
Revenue (ttm)772.93M
Net Income (ttm)77.89M
Shares Out574.33M
EPS (ttm)0.15
PE Ratio118.22
Forward PE60.41
Dividendn/a
Ex-Dividend Daten/a
Volume5,952,800
Average Volume25,115,567
Open17.04
Previous Close17.10
Day's Range16.76 - 17.74
52-Week Range7.51 - 25.00
Beta0.13
RSI69.69
Earnings DateAug 27, 2025

About HKG:6955

Shandong Boan Biotechnology Co., Ltd., a biopharmaceutical company, develops, manufactures, and markets biologics in Mainland China and internationally. Its commercialized products include Boyounuo (BA1101), an anti-VEGF humanized monoclonal antibody injection for mCRC, advanced metastatic or recurrent non-small cell lung cancer, recurrent glioblastoma, epithelial ovarian, fallopian tube or primary peritoneal cancer, cervical cancer and hepatocellular carcinoma indications; Boyoubei (BA6101), a human immunoglobulin G2 monoclonal antibody of the... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2013
Employees 760
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6955
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.